Fjarde AP Fonden Fourth Swedish National Pension Fund Has $19.63 Million Stake in Corteva, Inc. $CTVA

Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in shares of Corteva, Inc. (NYSE:CTVA) by 48.6% in the 1st quarter, HoldingsChannel.com reports. The fund owned 234,551 shares of the company’s stock after purchasing an additional 76,750 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Corteva were worth $19,634,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after buying an additional 317,538 shares in the last quarter. State Street Corp raised its position in Corteva by 3.7% in the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after purchasing an additional 1,290,071 shares during the last quarter. Franklin Resources Inc. increased its position in Corteva by 4.3% in the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after acquiring an additional 805,873 shares in the last quarter. Harris Associates L P increased its stake in shares of Corteva by 168.1% in the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares during the period. Finally, Northern Trust Corp grew its holdings in Corteva by 5.0% during the 4th quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock worth $786,385,000 after acquiring an additional 562,550 shares during the period. 81.54% of the stock is owned by institutional investors.

Corteva Price Performance

NYSE:CTVA opened at $85.63 on Friday. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.95. The firm has a market capitalization of $57.27 billion, a price-to-earnings ratio of 50.37, a P/E/G ratio of 2.62 and a beta of 0.56. The stock’s 50 day moving average price is $79.80 and its two-hundred day moving average price is $76.86. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter in the previous year, the firm posted $1.13 EPS. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s dividend payout ratio is 42.35%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CTVA. Morgan Stanley boosted their price target on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Argus boosted their target price on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, March 31st. BNP Paribas Exane increased their price target on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Mizuho lifted their price objective on Corteva from $94.00 to $96.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Berenberg Bank boosted their price objective on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research report on Thursday, March 26th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, Corteva currently has an average rating of “Moderate Buy” and an average price target of $88.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.